Shares of healthcare facilities firm, Apollo Hospitals Enterprise, hit their 52-week high of Rs 1,324, up 5% in intra-day trade so far, extending its past two days gain the BSE on Monday.
In November, Apollo Hospitals announced reorganisation of its pharmacy business by segregating the front-end of the business into a separate company and divestment of its 74.5% stake in the front-end business to investors on slump sale basis for Rs 5.3 billion.
In the past six months, the stock has outperformed the market by surging 43%, as compared to 3% rise in the S&P BSE Sensex. Analysts at
In November, Apollo Hospitals announced reorganisation of its pharmacy business by segregating the front-end of the business into a separate company and divestment of its 74.5% stake in the front-end business to investors on slump sale basis for Rs 5.3 billion.
In the past six months, the stock has outperformed the market by surging 43%, as compared to 3% rise in the S&P BSE Sensex. Analysts at